PXD060379 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Discovery of an ApoE4-Targeted Small-Molecule SirT1 Enhancer for the Treatment of Alzheimer’s Disease |
Description | Herein we describe the discovery of an orally brain-22 permeable small-molecule, DDL-218, that enhanced SirT1 in ApoE4-expressing neuronal cells 23 and a murine AD model. DDL-218 increased the transcription factor NFYb resulting in 24 upregulation of PRMT5. Mechanistic and modeling studies show that binding of ApoE4 to the 25 SirT1 gene promoter can be displaced by PRMT5 leading to increased SirT1 transcription. DDL-26 218 treatment elicited improvement in memory in the AD model, suggesting that DDL-218 27 enhancement of neurotrophic SirT1 in the brain has potential to modulate neuronal activity that 28 may clinically provide an improvement in cognitive function and complement the current anti-29 Aβ antibody monotherapy. Our findings support further development of DDL-218 as a novel 30 ApoE4-targeted therapeutic candidate for AD. |
HostingRepository | PRIDE |
AnnounceDate | 2025-05-07 |
AnnouncementXML | Submission_2025-05-07_06:59:06.732.xml |
DigitalObjectIdentifier | https://dx.doi.org/10.6019/PXD060379 |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Supported dataset by repository |
PrimarySubmitter | Jesus Campagna |
SpeciesList | scientific name: Mus musculus (Mouse); NCBI TaxID: 10090; |
ModificationList | phosphorylated residue; monohydroxylated residue; deamidated residue; iodoacetamide derivatized residue |
Instrument | Q Exactive |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2025-01-30 13:14:10 | ID requested | |
⏵ 1 | 2025-05-07 06:59:07 | announced | |
Publication List
10.1038/s41598-025-96131-2; |
Campagna J, Chandra S, Teter B, Cohn W, Pham J, Kim YS, Jagodzinska B, Vadivel K, Alam P, Bilousova T, Young M, Elias C, Marcucci J, Flacau I, Jackman A, Padder S, Wi D, Zhu C, Spilman P, Jung ME, Bredesen DE, John V, Discovery of an ApoE4-targeted small-molecule SirT1 enhancer for the treatment of Alzheimer's disease. Sci Rep, 15(1):14028(2025) [pubmed] |
10.6019/PXD060379; |
Keyword List
submitter keyword: sirtuin 1, PRMT5, NFYb, SirT1, SirT1 enhancer, memory,apolipoprotein E4 |
Contact List
Varghese John |
contact affiliation | The Drug Discovery Lab, Mary S. Easton Center for Alzheimer’s Disease Research, Department of Neurology, David Geffen School of Medicine, 710 Westwood Plaza, University of California Los Angeles, Los Angeles, CA 90095, USA |
contact email | vjohn@mednet.ucla.edu |
lab head | |
Jesus Campagna |
contact affiliation | UCLA |
contact email | jcampagna@mednet.ucla.edu |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2025/05/PXD060379 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD060379
- Label: PRIDE project
- Name: Discovery of an ApoE4-Targeted Small-Molecule SirT1 Enhancer for the Treatment of Alzheimer’s Disease